abstract |
The invention provides antibodies that specifically bind transthyretin (TTR). Antibodies can be used to treat or prevent diseases or disorders associated with accumulation of TTR or accumulation of TTR deposits (eg, TTR amyloidosis). Antibodies can also be used to diagnose TTR amyloidosis and inhibit or reduce TTR aggregation, among other uses. |